Variant report
Variant | nsv522572 |
---|---|
Chromosome Location | chr2:50092753-50108782 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:50100081-50100265 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr2:50095166-50095367 | HepG2 | liver: | n/a | chr2:50095275-50095286 |
3 | CTCF | chr2:50104530-50104585 | Lung_OC | lung: | n/a | n/a |
4 | E2F4 | chr2:50098956-50099347 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | GATA3 | chr2:50107987-50108096 | SH-SY5Y | brain: | n/a | n/a |
6 | JUN | chr2:50106199-50106394 | HepG2 | liver: | n/a | chr2:50106313-50106326 |
7 | JUND | chr2:50106177-50106495 | HepG2 | liver: | n/a | chr2:50106334-50106345 |
8 | KAP1 | chr2:50107667-50107988 | HEK293 | kidney: | n/a | n/a |
9 | MAFK | chr2:50098757-50098816 | HepG2 | liver: | n/a | n/a |
10 | MAFK | chr2:50100800-50101034 | HepG2 | liver: | n/a | n/a |
11 | POLR2A | chr2:50100183-50100222 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr2:50095539-50095743 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | SETDB1 | chr2:50095158-50095528 | U2OS | brain: | n/a | n/a |
14 | SETDB1 | chr2:50107712-50108095 | U2OS | brain: | n/a | n/a |
15 | TCF7L2 | chr2:50093038-50093177 | HepG2 | liver: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:50079020..50080937-chr2:50095314..50097003,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL7P13 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs111902943 | chr2:50100813-50100814 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs4461296 | chr2:50100835-50100836 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs1592729 | chr2:50100865-50100866 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs185115966 | chr2:50100905-50100906 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs571450269 | chr2:50100953-50100954 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs534124387 | chr2:50100990-50100991 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs147816819 | chr2:50104534-50104535 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs141364005 | chr2:50104548-50104549 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs187250958 | chr2:50104557-50104558 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs541390254 | chr2:50104580-50104581 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs567654683 | chr2:50107215-50107216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140860106 | chr2:50107216-50107217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189192789 | chr2:50107219-50107220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574784776 | chr2:50107222-50107223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs193057418 | chr2:50107223-50107224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539368909 | chr2:50107242-50107243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546732066 | chr2:50107260-50107261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566342304 | chr2:50107266-50107267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535878199 | chr2:50107273-50107274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554503359 | chr2:50107287-50107288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150170627 | chr2:50107319-50107320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544130634 | chr2:50107339-50107340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558365192 | chr2:50107380-50107381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115283465 | chr2:50107429-50107430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540801397 | chr2:50107442-50107443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559240923 | chr2:50107481-50107482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373810536 | chr2:50107551-50107552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146778101 | chr2:50107591-50107592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114041860 | chr2:50107605-50107606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375015979 | chr2:50107609-50107610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140537106 | chr2:50107616-50107617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568232897 | chr2:50107630-50107631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575967089 | chr2:50107642-50107643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184538552 | chr2:50107715-50107716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565349050 | chr2:50107719-50107720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145687375 | chr2:50107720-50107721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547969833 | chr2:50107744-50107745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138371434 | chr2:50107788-50107789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50107200-50107800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |